Financhill
Back

Akero Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
32

AKRO
Akero Therapeutics

Last Price:
$29.35
Seasonality Move:
-9.11%
Sell
19

NBY
NovaBay Pharmaceuticals

Last Price:
$0.53
Seasonality Move:
-0.66%
Sell
32
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $29.34. The Score for AKRO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $29.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.53
    The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 45.72 Sell
Chaikin Money Flow: 761403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.2 - 31.7) Sell
Bollinger Bands (100): (26.09 - 31.31) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 39.44 Sell
Chaikin Money Flow: 514099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.53 - 0.67) Sell
Bollinger Bands (100): (0.49 - 0.69) Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.33 Buy
20-day SMA: 30.54 Sell
50-day SMA: 30.81 Sell
200-day SMA: 25.92 Buy
8-day EMA: 29.44 Sell
20-day EMA: 30.1 Sell
50-day EMA: 30.09 Sell
200-day EMA: 27.83 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.54 Sell
20-day SMA: 0.57 Sell
50-day SMA: 0.63 Sell
200-day SMA: 1.88 Sell
8-day EMA: 0.54 Sell
20-day EMA: 0.57 Sell
50-day EMA: 0.64 Sell
200-day EMA: 4.7 Sell

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):